Indo Us Bio-Tech Stock

Indo Us Bio-Tech P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Indo Us Bio-Tech (INDOUS.NS) as of Aug 13, 2026 is 188.11. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -58.27 — a change of -422.83% (higher).

P/CF

188.11

YoY

-422.83%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Indo Us Bio-Tech is 2026 188.11 . P/CF (Price-to-Cash-Flow Ratio) of Indo Us Bio-Tech was 2025 -58.27 . It decreases by -422.83% higher compared to the previous year.
Access this data via the Eulerpool API

Indo Us Bio-Tech Stock analysis

What does Indo Us Bio-Tech do? Indo Us Bio-Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indo Us Bio-Tech stock

P/CF (Price-to-Cash-Flow Ratio) of Indo Us Bio-Tech is 188.11 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Indo Us Bio-Tech changed from -58.27 to 188.11, representing a -422.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Indo Us Bio-Tech since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Indo Us Bio-Tech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Indo Us Bio-Tech

All Key Metrics — Indo Us Bio-Tech